4 天之前 · Insulet Corporation is an innovative medical device company based in Acton, Massachusetts. It was founded in 2000 with the mission of improving the lives of people with diabetes. Specifically, through our revolutionary Omnipod Insulin Management System, we seek to expand the use of insulin pump therapy.

查看最新的Insulet公司 (PODD) 股票報價、記錄、新聞及其他重要資訊，助你賣買股票及投資。

U.S. Omnipod revenue is expected to grow 16%-20%, driven by the continued ramp-up of type 2 diabetes adoption and innovations like G7 and Libre 2 Plus integrations. International Omnipod revenue...

2025年3月9日 · It might be of some concern to shareholders to see the Insulet Corporation (NASDAQ:PODD) share price down 11% in the last month. But the silver lining is the stock is up over five years. However...

5 天之前 · View the latest PODD 10K form and other Securities and Exchange Commission (SEC) filings for Insulet (NASDAQ:PODD) at MarketBeat.

2025年2月20日 · Insulet (PODD) reported $597.5 million in revenue for the quarter ended December 2024, representing a year-over-year increase of 17.2%. EPS of $1.15 for the same period compares to $1.40 a year...

2024年11月21日 · Insulet Corporation trades at exorbitant multiples despite expected growth outcomes. Read why PODD remains a hold on valuations in my view.

2025年3月12日 · Should I buy Insulet (PODD)? Use the Zacks Rank and Style Scores to find out is PODD is right for your portfolio.

2025年2月20日 · Insulet (PODD Quick Quote PODD - Free Report) came out with quarterly earnings of $1.15 per share, beating the Zacks Consensus Estimate of $1.05 per share. This compares to earnings of $1.40...

2025年1月7日 · Medical devices maker Insulet (PODD) counts its revenue growth among its strong points. Insulet stock is today's selection for IBD 50 Stocks To Watch. Third-quarter sales accelerated from the...